Optimization of treatment in Turner's syndrome

Journal of Pediatric Endocrinology and Metabolism

Volumn 17, Issue SUPPL. 3, 2004, Pages 427-434

  Bouthelier, R Gracia ^a   Iguacel, A Oliver ^a   Gonzalez Casado, Isabel ^a   de Alvare, A Alcalde ^a  

^a HOSPITAL INFANTIL LA PAZ   (Spain)

Author keywords

Estrogen treatment; Growth; Hypogonadism; Recombinant human growth hormone; Turner's syndrome

Indexed keywords

CONJUGATED ESTROGEN; EQUIN; ESTRADERM M; ESTRADIOL; ESTRADIOL VALERATE; ESTROGEN; ETHINYLESTRADIOL; HUMAN GROWTH HORMONE; OXANDROLONE; RECOMBINANT GROWTH HORMONE;

ARTICLE; BODY HEIGHT; BONE DENSITY; BONE MINERAL; CHILD; CHILDHOOD DISEASE; CLINICAL FEATURE; DRUG DOSE REGIMEN; DRUG POTENTIATION; DRUG RESPONSE; HUMAN; HYPOGONADISM; LOW DRUG DOSE; MENARCHE; OPTIMAL DRUG DOSE; OSTEOPENIA; OVARY INSUFFICIENCY; PUBERTY; SHORT STATURE; SPAIN; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TURNER SYNDROME;

GROWTH HORMONE; HUMANS; OXANDROLONE; RECOMBINANT PROTEINS; TREATMENT OUTCOME; TURNER SYNDROME;

EID: 3142727301     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Suwa S. Standards for growth and growth velocity in Turner's syndrome. Acta Paediatr Jpn 1992; 34: 206-221.
2. Lippe B, Frane J. Growth in Turner syndrome: the United States experience. In: Ranke MB, Rosenfeld RG, eds. Turner Syndrome: Growth Promoting Therapies. Amsterdam: Excerpta Medica/Elsevier, 1990; 59-63.
3. Naeraa RW, Nielsen J. Standards for growth and final height in Turner's syndrome. Acta Paediatr Scand 1990; 79: 182-190.
4. Lyon AJ, Preece MA, Grant DB. Growth curve for girls with Turner syndrome. Arch Dis Child 1985; 60: 932-935.
5. Rochiccioli P, Chaussain JL. Final height in patients with Turner syndrome treated with growth hormone (n=117). In: Albertsson-Wikland K, Ranke MB, eds. Turner Syndrome in a Life Span Perspective: Research and Clinical Aspects. Amsterdam: Elsevier, 1995; 123-128.
6. Taback SP, Collu R, Deal CL, Guyda HJ, Salisbury S, Dean HJ, Van Vliet G. Does growth-hormone supplementation affect adult height in Turner's syndrome? Lancet 1996; 348: 25-27.
7. Chu CE, Paterson WF, Kelnar CJH, Smail PJ, Greene SA, Donaldson MDC. Variable effect of growth hormone on growth and final adult height in Scottish patients with Turner's syndrome. Acta Paediatr 1997; 86: 160-164.
8. Rosenfeld RG, Attie KM, Frane J, Brasel JA, Burstein S, Cara JF, Chernausek S, Gotlin RW, Kuntze J, Lippe BM, Mahoney CP, Moore WV, Saenger P, Johanson AJ. Growth hormone therapy of Turner's syndrome: beneficial effect on adult height. J Pediatr 1998; 132: 319-324.
9. Takano K, Ogawa M, Okada Y, et al. Final height and long term effects after growth hormone therapy in Turner syndrome: results of a 6-year multicentre study in Japan. In: Albertsson-Wikland K, Ranke MB, eds. Turner Syndrome in a Life Span Perspective: Research and Clinical Aspects. Amsterdam: Elsevier Science, 1995; 113-121.
10. de Muinck Keizer-Schrama SM, van de Broeck J, Sas T, Hokken-Koelega A. Final height of growth hormone-treated GH-deficient children and girls with Turner's syndrome: the Dutch Experience. The Dutch Advisory Group on Growth Hormone. Hom Res 1999; 51 (Suppl 3): 127-131.
11. Ranke MB, Lindberg A, Chatelain P, Cutfield W, Albertsson-Wikland K, Wilton P, Price DA. Turner syndrome: demography, auxology and growth during growth hormone therapy in KIGS. In: Ranke MB, Wilton P, eds. Growth Hormone Therapy in KIGS - 10 Years Experience. Heidelberg: JA Barth, 1999; 245-258.
12. Plotnick L, Attie KM, Blethen SL, Sy JP. Growth hormone treatment of girls with Turner's syndrome: The National Cooperative Growth Study experience. Pediatrics 1998; 102: 479-481.
13. Cacciari E. Spontaneous growth and results of growth hormone therapy in patients with Turner syndrome. In: Albertsson-Wikland K, Ranke MB, eds. Turner Syndrome in a Life Span Perspective: Research and Clinical Aspects. Amsterdam: Elsevier Science, 1995; 129-135.
14. Dacou-Voutetakis C, Karavanaki-Karanassiou K, Petrou V, Georgopoulos N, Maniati-Christidi M, Mavrou A. The growth pattern and final height of girls with Turner's syndrome with and without human growth hormone treatment. Pediatrics 1998; 101: 663-668.
15. Haeusler G, Schmitt K, Blumel P, Plochl E, Waldhor T, Frisch H. Growth hormone in combination with anabolic steroids in patients with Turner syndrome: effect on bone maturation and final height. Acta Paediatr 1996; 85: 1408-1414.
16. Heinrich C, Shepper J, Tomas M, et al. Final height in 46 girls with Turner syndrome treated with growth hormone in Belgium: evaluation of height recovery and predictive factors. In: Albertsson-Wikland K, Ranke MB, eds. Turner Syndrome in a Life Span Perspective: Research and Clinical Aspects. Amsterdam: Elsevier Science, 1995; 137-146.
17. Massa G, van de Broeck J, Attanasio A, et al. Final height results of the Lilly European Turner studies. In: Albertsson Wikland K, Ranke MB, eds. Turner Syndrome in a Life Span Perspective: Research and Clinical Aspects. Amsterdam: Elsevier Science, 1995; 155-158.
18. Cacciari E, Mazanti L. Final height of patients with Turner's syndrome treated with growth hormone (GH): indications for GH therapy alone at high doses and late estrogen therapy. Italian Study Group for Turner Syndrome. J Clin Endocrinol Metab 1999; 84: 4510-4515.
19. de Muinck Keizer-Schrama SM, van de Broeck J, Sas T, et al. Final height in Turner syndrome: Dutch study. 5th International Turner Symposium, Optimizing Health care for Turner patients in the 21st Century, 23-25 March, 2000, Naples, Italy.
20. Bramswig JH. Long-term results of growth hormone therapy in Turner syndrome. Endocrine 2001; 15: 5-13.
21. Stahnke N, Keller E, Landy H, the Serono Study Group. Favorable final height outcome in girls with Ullrich-Turner syndrome treated with low-dose growth hormone together with oxandrolone despite starting treatment after 10 years of age. J Pediatr Endocrinol Metab 2002; 15: 129-138.
22. Nilsson KO, Albertsson-Wikland K, Alm J, Aronson S, Gustafsson J, Hagenas L, Hager A, Ivarsson SA, Karlberg J, Kristrom B, Marcus C, Moell C, Ritzen M, Tuvemo T, Wattsgard C, Westgren U, Westphal O, Aman J. Improved final height in girls with Turner syndrome treated with growth hormone and oxandrolone. J Clin Endocrinol Metab 1996; 81: 635-640.
23. Quigley CA, Crowe BJ, Anglin DG, Chipman JJ. Growth hormone and low dose estrogen in Turner syndrome: results of a United States multi-center trial to near-final height. J Clin Endocrinol Metab 2002; 87: 2033-2041.
24. Johnston DI, Betts P, Dunger D, Barnes N, Swift PG, Buckler JM, Butler GE. A multicentre trial of recombinant growth hormone and low dose oestrogen in Turner syndrome: near final height analysis. Arch Dis Child 2001; 84: 76-81.
25. Reiter EO, Blethen SL, Baptista J, Price L. Early initiation of growth hormone treatment allows age-appropiate estrogen use in Turner's syndrome. J Clin Endocrinol Metab 2001; 86: 1936-1941.
26. Guarneri MP, Abusrewil SAS, Bernasconi S, Bona G, Cavallo L, Cicognani A, Di Battista E, Salvatoni A. Turner's syndrome. J Pediatr Endocrinol Metab 2001; 14 (Suppl 2): 959-965.
27. Ross JL, Cassorla FG, Skerda MC, Valk IM, Loriaux DL, Cutler GB Jr. A preliminary study of the effect of estrogen dose on growth in Turner's syndrome. N Engl J Med 1983; 309: 1104-1106.
28. Sas TCJ, de Muinck Keizer-Schrama SMPF, Stijnen T, van Teunenbroek A, van Leeuwen WJ, Asarfi A, van Rijn RR, Drop SL, Dutch Advisory Group on Growth Hormone. Bone mineral density assessed by phalangeal radiographic absorptiometry before and during long-term growth hormone treatment in girls with Turner's syndrome participating in a randomized dose-response study. Pediatr Res 2001; 50: 417-422.
29. Chernausek SD, Attie KM, Cara JF, Rosenfeld RG, Frane J. Growth hormone therapy of Turner syndrome: the impact of age of estrogen replacement on final height. Genentech, Inc., Collaborative Study Group. J Clin Endocrinol Metab 2000; 85: 2439-2445.
30. Attie KM, Chernausek S, Frane J, Rosenfeld RG, for the Genetech Study Group. Growth hormone use in Turner syndrome: a preliminary report on the effect of early versus delayed estrogen. In: Albertsson-Wikland K, Ranke MB, eds. Turner Syndrome in a Life-span Perspective. Amsterdam: Elsevier Science, 1995; 175-181.